Who owns CHEMOMAB THERAPEUTICS LTD?
- Ticker: CMMB
- CUSIP Number: 16385c104
Tip: Access positions for across all investors
Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chemomab Therapeutics stock
Who bought or sold CHEMOMAB THERAPEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 2.2M | $1.7M | 0% | Mar 2024 |
|
| Ikarian Capital | 213k | $166k | 0% | Mar 2024 |
|
| Two Sigma Investments | 40k | $31k | -29% | Mar 2024 |
|
| Two Sigma Advisers | 38k | $29k | 7% | Mar 2024 |
|
| Kestra Private Wealth Services | 31k | $24k | 0% | Mar 2024 |
|
| Boothbay Fund Management | 27k | $21k | 0% | Mar 2024 |
|
| Two Sigma Securities | 26k | $20k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 19k | $15k | 0% | Mar 2024 |
|
| Geode Capital Management | 12k | $9.1k | 0% | Mar 2024 |
|
| Susquehanna International | 12k | $8.9k | 100% | Mar 2024 |
|
| Morgan Stanley | 2.8k | $2.2k | 100% | Mar 2024 |
|
| Moser Wealth Advisors | 500.00 | $390.000000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 44.00 | $33.998800 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.00 | $1.000000 | 100% | Mar 2024 |
|
Who sold out of Chemomab Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2023 | 33k | $17k |
| Virtu Financial | Dec 2023 | 26k | $13k |
| Millennium Management | Dec 2023 | 20k | $10k |
| Advisor Group Holdings | Dec 2023 | 585.00 | $297.004500 |